Literature DB >> 35040084

Reproductive Issues and Pregnancy Implications in Systemic Sclerosis.

Maria-Grazia Lazzaroni1, Francesca Crisafulli1, Liala Moschetti1, Paolo Semeraro1, Ana-Rita Cunha2, Agna Neto3, Andrea Lojacono4, Francesca Ramazzotto5, Cristina Zanardini5, Sonia Zatti5, Paolo Airò1, Angela Tincani1,6, Franco Franceschini1, Laura Andreoli7.   

Abstract

Systemic sclerosis (SSc) is a rare systemic autoimmune disease that can influence reproductive health. SSc has a strong female predominance, and the disease onset can occur during fertility age in almost 50% of patients. Preconception counseling, adjustment of treatment, and close surveillance during pregnancy by a multidisciplinary team, are key points to minimize fetal and maternal risks and favor successful pregnancy outcomes. The rates of spontaneous pregnancy losses are comparable to those of the general obstetric population, except for patients with diffuse cutaneous SSc and severe internal organ involvement who may carry a higher risk of abortion. Preterm birth can frequently occur in women with SSc, as it happens in other rheumatic diseases. Overall disease activity generally remains stable during pregnancy, but particular attention should be paid to women with major organ disease, such as renal and cardiopulmonary involvement. Women with such severe involvement should be thoroughly informed about the risks during pregnancy and possibly discouraged from getting pregnant. A high frequency of sexual dysfunction has been described among SSc patients, both in females and in males, and pathogenic mechanisms of SSc may play a fundamental role in determining this impairment. Fertility is overall normal in SSc women, while no studies in the literature have investigated fertility in SSc male patients. Nevertheless, some considerations regarding the impact of some immunosuppressive drugs should be done with male patients, referring to the knowledge gained in other rheumatic diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Fertility; Preconception counseling; Pregnancy; Reproductive issues; Systemic sclerosis

Year:  2022        PMID: 35040084     DOI: 10.1007/s12016-021-08910-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  126 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 2.  Cardiovascular Disease in Antiphospholipid Syndrome.

Authors:  Kali Polytarchou; Dimitrios Varvarousis; Antonis S Manolis
Journal:  Curr Vasc Pharmacol       Date:  2020       Impact factor: 2.719

3.  Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.

Authors:  A Brucato; M Frassi; F Franceschini; R Cimaz; D Faden; M P Pisoni; M Muscarà; G Vignati; M Stramba-Badiale; L Catelli; A Lojacono; I Cavazzana; A Ghirardello; F Vescovi; P F Gambari; A Doria; P L Meroni; A Tincani
Journal:  Arthritis Rheum       Date:  2001-08

4.  EULAR recommendations for the management of antiphospholipid syndrome in adults.

Authors:  Angela Tincani; Michael M Ward; Maria G Tektonidou; Laura Andreoli; Marteen Limper; Zahir Amoura; Ricard Cervera; Nathalie Costedoat-Chalumeau; Maria Jose Cuadrado; Thomas Dörner; Raquel Ferrer-Oliveras; Karen Hambly; Munther A Khamashta; Judith King; Francesca Marchiori; Pier Luigi Meroni; Marta Mosca; Vittorio Pengo; Luigi Raio; Guillermo Ruiz-Irastorza; Yehuda Shoenfeld; Ljudmila Stojanovich; Elisabet Svenungsson; Denis Wahl
Journal:  Ann Rheum Dis       Date:  2019-05-15       Impact factor: 19.103

Review 5.  Preconception Counseling.

Authors:  Monika Østensen
Journal:  Rheum Dis Clin North Am       Date:  2017-03-14       Impact factor: 2.670

6.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 7.  Latest update on the Ro/SS-A autoantibody system.

Authors:  J Schulte-Pelkum; M Fritzler; M Mahler
Journal:  Autoimmun Rev       Date:  2009-02-12       Impact factor: 9.754

Review 8.  Epidemiology of systemic sclerosis.

Authors:  T A Medsger
Journal:  Clin Dermatol       Date:  1994 Apr-Jun       Impact factor: 3.541

9.  Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.

Authors:  Vincent Sobanski; Angélique Lemaire-Olivier; Jonathan Giovannelli; Luc Dauchet; Myriam Simon; Benjamin Lopez; Cécile Yelnik; Marc Lambert; Pierre-Yves Hatron; Eric Hachulla; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

10.  Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Authors:  J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Oliver Distler; Dinesh Khanna; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; Martin Doelberg; Harbajan Chadha-Boreham; Harald Heinzl; Daniel M Rosenberg; Vallerie V McLaughlin; James R Seibold
Journal:  Ann Rheum Dis       Date:  2013-05-18       Impact factor: 19.103

View more
  1 in total

1.  Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor.

Authors:  P Triggianese; R Senter; A Petraroli; A Zoli; M Lo Pizzo; D Bignardi; E Di Agosta; S Agolini; F Arcoleo; O Rossi; S Modica; E Greco; M S Chimenti; G Spadaro; C De Carolis; M Cancian
Journal:  Front Med (Lausanne)       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.